Cancer

All Items

• 

  Clear cell urothelial carcinoma of the urinary bladder - a rare pathological entity. A case report and a systematic review of the literature

  Ioana Mihai, Sorina Taban, Alin Cumpanas, Emilian Gh. Olteanu, Mihaela Iacob, Alis Dema

  400-403
• 

  EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth

  Jing-cai Niu, Nan Ma, Wei Liu, Pei-ji Wang

  265-273
• 

  PCAT1 is a poor prognostic factor in endometrial carcinoma and associated with cancer cell proliferation, migration and invasion

  Xiaohuan Zhao, Yali Fan, Changqiong Lu, Hongfang Li, Ning Zhou, Gaogao Sun, Hong Fan

  274-281
• 

  Valspodar-modulated chemotherapy in human ovarian cancer cells SK-OV-3 and MDAH-2774

  Maciej Zalewski, Julita Kulbacka, Jolanta Saczko, Małgorzata Drag-Zalesinska, Anna Choromanska

  234-241
• 

  Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients

  Ilija Vladimir Baroš, Nataša Tanasković, Ulrika Pellas, Živka Eri, Ljiljana Tadić Latinović, Tibor Tot

  242-248
• 

  How latent viruses cause breast cancer: An explanation based on the microcompetition model

  Hanan Polansky, Hava Schwab

  221-226
• 

  Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer

  Farhan S. Cyprian, Saghir Akhtar, Zoran Gatalica, Semir Vranic

  227-233
• 

  Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy

  Xin-xin Du, Rong Yu, Zhen-fei Wang, De-cheng Du, Qiao-yun Liu, Run-mei Wang, Shi-rong Kang, Hao Yang

  186-194
• 

  An exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions

  Fikri Selcuk Simsek, Muhammet Arslan, Yusuf Dag

  195-200
• 

  Genetic secrets of long-term glioblastoma survivors

  Ivana Jovčevska

  116-124
• 

  Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer

  Wei Zhang, Lunhua Huang, Xinyang Lu, Kecheng Wang, Xiaofei Ning, Zhiqiang Liu

  164-171
• 

  Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC)

  Peng Li, Mingqiang Dong, Zhigang Wang

  146-154
• 

  Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study

  Sibel Cetintas, Gulcin Tezcan, Berrin Tunca, Unal Egeli, Mustafa Sehsuvar Gokgoz, Gulsah Cecener

  172-179
• 

  Age- and gender-independent association of glutathione S-transferase null polymorphisms with chronic myeloid leukemia

  Abdel Rahim Mahmoud Muddathir, Elharam Ibrahim Abdallah, Omar Falah Khabour, Ream Elzain Abdelgader, Mahmoud Mohamed Elgari

  350-354
• 

  The effect of micro-sized titanium dioxide on WM-266-4 metastatic melanoma cell line

  Tanja Prunk Zdravković, Bogdan Zdravković, Mojca Lunder, Polonca Ferk

  60-66
• 

  Cannabinoids in cancer treatment: Therapeutic potential and legislation

  Barbara Dariš, Mojca Tancer Verboten, Željko Knez, Polonca Ferk

  14-23
• 

  MicroRNAs: Recent insights towards their role in male infertility and reproductive cancers

  Muhammad Babar Khawar, Rabia Mehmood, Nabila Roohi

  31-42
• 

  Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway

  Jianjun Han, Jingjing Yu, Yu'na Dai, Jumei Li, Meiyan Guo, Jingzhen Song, Xuefeng Zhou

  52-59
• 

  Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas

  Hale Demir, Ozgecan Dulgar, Bugra Taygun Gulle, Hande Turna, Sennur Ilvan

  313-319
• 

  Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures

  Nesrine Essid, Jean Claude Chambard, Amel Benammar Elgaaïed

  336-346